Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica.
Utilization of ferrioxamines as sole sources of iron distinguishes Salmonella enterica serotypes Typhimurium and Enteritidis from a number of related species, including Escherichia coli. Ferrioxamine supplements have therefore been used in preenrichment and selection media to increase the bacterial growth rate while selectivity is maintained. We characterized the determinants involved in utilization of ferrioxamines B, E, and G by S. enterica serotype Typhimurium by performing siderophore cross-feeding bioassays. Transport of all three ferric siderophores across the outer membrane was dependent on the FoxA receptor encoded by the Fur-repressible foxA gene. However, only the transport of ferrioxamine G was dependent on the energy-transducing protein TonB, since growth stimulation of a tonB strain by ferrioxamines B and E was observed, albeit at lower efficiencies than in the parental strain. Transport across the inner membrane was dependent on the periplasmic binding protein-dependent ABC transporter complex comprising FhuBCD, as has been reported for other hydroxamate siderophores of enteric bacteria. The distribution of the foxA gene in the genus Salmonella, as indicated by DNA hybridization studies and correlated with the ability to utilize ferrioxamine E, was restricted to subspecies I, II, and IIIb, and this gene was absent from subspecies IIIa, IV, VI, and VII (formerly subspecies IV) and Salmonella bongori (formerly subspecies V). S. enterica serotype Typhimurium mutants with either a transposon insertion or a defined nonpolar frameshift (+2) mutation in the foxA gene were not able to utilize any of the three ferrioxamines tested. A strain carrying the nonpolar foxA mutation exhibited a significantly reduced ability to colonize rabbit ileal loops compared to the foxA+ parent. In addition, a foxA mutant was markedly attenuated in mice inoculated by either the intragastric or intravenous route. Mice inoculated with the foxA mutant were protected against subsequent challenge by the foxA+ parent strain.
Kingsley
R A
RA
Department of Microbiology and Immunology, University of Leicester, Leicester LE1 9HN, United Kingdom.
Reissbrodt
R
R
Rabsch
W
W
Ketley
J M
JM
Tsolis
R M
RM
Everest
P
P
Dougan
G
G
Bäumler
A J
AJ
Roberts
M
M
Williams
P H
PH
D000595:Amino Acid Sequence; D000818:Animals; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics / Q000378:metabolism; D001483:Base Sequence; D001692:Biological Transport; D003676:Deferoxamine / Q000378:metabolism; D029968:Escherichia coli Proteins; D005290:Ferric Compounds / Q000378:metabolism*; D005798:Genes, Bacterial; D007082:Ileum / Q000382:microbiology / Q000503:physiopathology; D007502:Iron Chelating Agents / Q000378:metabolism; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D010456:Peptides, Cyclic / Q000378:metabolism; D011817:Rabbits; D011956:Receptors, Cell Surface; D012481:Salmonella Infections, Animal / Q000382:microbiology; D012486:Salmonella typhimurium / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D017422:Sequence Analysis, DNA; D017262:Siderophores / Q000378:metabolism*
D001425:Bacterial Outer Membrane Proteins; D029968:Escherichia coli Proteins; D005290:Ferric Compounds; C489524:FoxA protein, bacteria; C489523:FoxB protein, E coli; D007502:Iron Chelating Agents; D010456:Peptides, Cyclic; D011956:Receptors, Cell Surface; D017262:Siderophores; C072460:foxR protein, bacteria; C017508:ferrioxamine E; C002577:ferrioxamine B; D003676:Deferoxamine